Jpmorgan Chase & CO Daxor Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DXR
# of Institutions
11Shares Held
87.3KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.8KShares$468,7480.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8KShares$142,2810.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL14.6KShares$140,2750.07% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ7.2KShares$69,1200.0% of portfolio
-
Ubs Group Ag1.24KShares$11,8650.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $38.8M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...